標題：重金求購“DTaP/IPV”《 BP2015 》的藥典標準一份. 詳細要求： 需求名稱：Diphtheria, Tetanus, Pertussis (Acellular Component) and Inactivated Poliomyelitis Vaccine, Adsorbed的藥典標準 具體要求：英文原文電子版，最好有中文 要求時間：請在2019年1月22日之前 交稿方式：直接點擊交稿在線交稿就是了，我會每天過來看的，謝謝各位藥智的戰(zhàn)友們   [更多]

公司在進行羥丙甲纖維素空心膠囊的研發(fā)工作，尋找國外藥典的相關(guān)標準，希望有此信息的人能提供一下，非常感謝！   [更多]

本人需要符合最新新藥注冊申報要求的小容量凍干粉針凍干工藝優(yōu)化方案，包含處方優(yōu)化，穩(wěn)定性考察，特別是凍干工藝優(yōu)化等，越具體越好。   [更多]

求購雷米普利原料及片最新權(quán)威標準 BP2019版藥典標準和USP42版藥典標準   [更多]

求購：USP Monographs: Temozolomide for Injection”《 USP41-NF36 》的美國藥典（USP41-NF36 ）標準一份   [更多]

求購“USP Monographs: Teriparatide Injection”《 USP41-NF36 》的藥典標準一份.   [更多]

“Formulated Preparations: Specific Monographs: Inositol Nicotinate Tablets”《 BP2019 》的藥典標準一份.   [更多]

最好能附帶原料藥標準   [更多]

1、Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), Volume: 9, Pages: 957-64(in English 964), Journal, 1936. 2、Chemicke Listy pro Vedu a Prumysl, Volume: 37, Pages: 289-90, Journal, 1943. 3、Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer. 4. Drugs Today (Barc). 2018 Sep;54(9):519-533. doi: 10.1358/dot.2018.54.9.2776624. An update on tolvaptan for autosomal dominant polycystic kidney disease. Poch E1, Rodas L2, Blasco M2, Molina A2, Quintana L2. 5.Parameter optimization and process control for the sterilization of ornidazole and sodium chloride injection 6.Physical and pharmacotechnological studies of ornidazole drug 7. Analytical studies for the determination of ornidazole in the presence of degradation products By Visan, Veronica; Ionescu, Mariana S.; Dragos, Mariana; Belu, Dan; Cosofret, Vasile From Revistade Chimie (Bucharest, Romania) (1989), 40(8), 728-31. Language: Romanian, Database: CAPLUS 8. Reactions of nitroimidazoles with free radicals--enhancement of reaction by u.v. irradiation By Moore D E From International journal of radiation biology and related studies in physics, chemistry, and medicine (1985), 47(5),563-8, Language: English, Database: MEDLINE   [更多]

1. Miller J. Ogidigben, Teh-Ching Chu and David E. Potter. Naphazoline-induced neuroendocrine changes Increases in ANP and cGMP levels 2. Robert J. Dockhorn and Thomas G. Duckett. Comparison of Naphcon-A and Its components 3. Mark B, Abelson MD, Salim I, et al. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage 4. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flowinvolvement of central and peripheral alpha(2) I(1) receptors 5. The efficacy of long-term treatment with Tolvaptan to prolong the time until dialysis initiation in patients with chronic kidney disease and heart failure 6. Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion 7. Tolvaptan Efficiently Reduces Intracellular Fluid Working Toward a Potential Treatment Option for Cellular Edema 8. Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites 9. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease 10. Safety and Effectiveness of Tolvaptan Administration after Total Arch Replacement 11. Nephrol Dial Transplant. 2018 Oct 12. doi 10.1093ndtgfy297. [Epub ahead of print] 12. Nephrol Dial Transplant. 2018 Oct 11. doi 10.1093ndtgfy298. [Epub ahead of print] 13. Development and validation of RP-HPLC method for simultaneous estimation of Ofloxacin and Ornidazole inpresence of Ornidazole Impurity in combined pharmaceutical dosage form 14. Stability-indicating methods for the determination of Ornidazole in the presence of its degradate according to ICH guidelines 15. A sensitive HPLC method of determination of 2-methyl 5-nitro imidazole & reaction mass of intermediates of ornidazole in ornidazole bulk manufacturing 16. Development and validation of a reversed-phase HPLC method for the analysis of ornidazole in pharmaceutical dosage forms 17. On the hydrolytic behavior of tinidazole, metronidazole,   [更多]